Average Co-Inventor Count = 8.53
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Roche Glycart Ag (11 from 68 patents)
2. Hoffmann-la Roche Inc. (6 from 4,943 patents)
3. Engmab Sarl (4 from 5 patents)
4. Bristol-myers Squibb Compnay (1 from 3,684 patents)
5. Engmab Ag (1 from 1 patent)
6. Engmab Beta Holdings LLC (0 patent)
23 patents:
1. 12286486 - Anti-FAP antibodies and methods of use
2. 12215155 - Antibodies binding to CD3 and CD19
3. 12139553 - T cell activating bispecific antigen binding molecules
4. 11952421 - Bispecific antibodies against CD3EPSILON and ROR1
5. 11780920 - Antibodies binding to CD3 and CD19
6. 11672858 - Bispecific antibody molecules binding to CD3 and TYRP-1
7. 11591397 - Bispecific antibody molecules binding to CD3 and EGFRvIII
8. 11332545 - Anti-FAP antibodies and methods of use
9. 11111312 - Mutant interleukin-2 polypeptides
10. 10882918 - Bispecific T cell activating antigen binding molecules
11. 10851171 - Method for the selection of antibodies against BCMA
12. 10683369 - Monoclonal antibodies against BCMA
13. 10577429 - Anti-FAP antibodies and methods of use
14. 10323098 - Mutant interleukin-2 polypeptides
15. 10253110 - Anti-FAP antibodies and methods of use